Markus Renschler

President at CYTEIR THERAPEUTICS, INC.

65 year

Health Technology

Consumer Services

Profile

Markus F.
Renschler is President & Director at Cyteir Therapeutics, Inc. since 2018.
Former roles include Senior Vice President & Global Head-Hematology at Celgene Corp., Senior VP-Oncology Clinical Development at Pharmacyclics LLC from 1996 to 2007, Vice President-Clinical Development at Pharmion Corp.
from 2007 to 2008, Associate Professor at Stanford University, and Chief Medical Officer & Senior Vice President at Celgene Cellular Therapeutics from 2008 to 2017.
Education includes a doctorate from Stanford University and an undergraduate degree from Princeton University.

Markus Renschler active positions

Companies	Position	Start
CYTEIR THERAPEUTICS, INC.	President	01/01/2018

All active positions of Markus Renschler

Former positions of Markus Renschler

Companies	Position	End
Celgene Cellular Therapeutics Celgene Cellular Therapeutics Pharmaceuticals: MajorHealth Technology Develops human pharmaceuticals	Chief Tech/Sci/R&D Officer	01/01/2017
Stanford University Stanford University Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	01/01/2015
Pharmion Corp. Pharmion Corp. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of products for the treatment of hematology & oncology patients	Chief Tech/Sci/R&D Officer	01/01/2008
PHARMACYCLICS, INC.	Chief Tech/Sci/R&D Officer	28/12/2007
CELGENE	Chief Tech/Sci/R&D Officer	-

See the detail of Markus Renschler's experience

Training of Markus Renschler

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Markus Renschler's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	7
Celgene Corp. Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs	Health Technology
Pharmacyclics LLC Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis	Health Technology
Pharmion Corp. Pharmion Corp. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of products for the treatment of hematology & oncology patients	Health Technology
Stanford University Stanford University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Princeton University Princeton University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Cyteir Therapeutics, Inc. Cyteir Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage oncology company	Health Technology
Celgene Cellular Therapeutics Celgene Cellular Therapeutics Pharmaceuticals: MajorHealth Technology Develops human pharmaceuticals	Health Technology